Interferon beta remains a cornerstone disease-modifying therapy in relapsing forms of multiple sclerosis. However, its utility is compromised by immunogenicity, whereby patients develop anti-drug ...

An inhaled form of interferon — a drug commonly used to treat multiple sclerosis by injection — may help protect hospitalized Covid-19 patients from getting worse, according to a British drugmaker.

Drugs called interferon betas are common treatments for multiple sclerosis (MS), reducing relapses and slowing motor function decline. Interferon beta, a protein known to contain a zinc binding pocket ...

A new study found extensive alternative splicing of messenger RNA in the blood cells of untreated multiple sclerosis patients compared to healthy controls. The study, which showed that highly ...

Whether combined treatment with recombinant interferon beta-1b and lopinavir–ritonavir reduces mortality among patients hospitalized with Middle East respiratory syndrome (MERS) is unclear. We ...

Betaseron (interferon beta-1b) is a prescription drug that treats certain types of multiple sclerosis (MS) and clinically isolated syndrome in adults. It’s given as an injection under your skin.

Amid the coronavirus disease (COVID-19) pandemic, scientists and health experts race to develop drugs and vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Many ...

CHICAGO — The use of a clinically validated flow cytometry test can assess type 1 and type 2 interferon activity in children with various pediatric inflammatory diseases to evaluate and monitor their ...

Pegylated interferon beta-1a (Plegridy) was separated from the MTA of beta interferons and glatiramer acetate for treating multiple sclerosis because a separate single technology appraisal for this ...

The MTA ‘Multiple sclerosis - interferon beta, glatiramer acetate (review TA32) [ID809]’ has been suspended to allow NICE to reconcile the submissions made by stakeholders and the Assessment Group ...